Clinical and economic benefits of de-escalating stress ulcer prophylaxis therapy in the intensive care unit: A quality improvement study

Anaesth Intensive Care. 2019 Nov;47(6):503-509. doi: 10.1177/0310057X19860972. Epub 2019 Oct 9.

Authors

Affiliations

¹ Sir Charles Gairdner Hospital, Perth, Australia.
² School of Public Health, Curtin University, Perth, Australia.
³ Fiona Stanley Hospital, Perth, Australia.
⁴ St John of God Hospital, Perth, Australia.
⁵ Bunbury Regional Hospital, Bunbury, Australia.
⁶ Institute for Health Research, University of Notre Dame, Perth, Australia.
⁷ Rockingham Hospital, Perth, Australia.
⁸ Royal Perth Hospital, Perth, Australia.

PMID: 31594383
DOI: 10.1177/0310057X19860972

No abstract available

Keywords: Intensive care medicine; pharmacist prescribing; proton pump inhibitors; quality improvement; stress ulcer prophylaxis.

MeSH terms

Acute Disease
Adult
Aged
Anti-Ulcer Agents / economics
Anti-Ulcer Agents / therapeutic use*
Australia
Humans
Intensive Care Units
Middle Aged
Patient Education as Topic
Peptic Ulcer / economics
Peptic Ulcer / prevention & control*
Peptic Ulcer / therapy*
Pharmacists
Prospective Studies
Proton Pump Inhibitors / economics
Proton Pump Inhibitors / therapeutic use
Quality Improvement*
Stress, Physiological*
Stress, Psychological / complications*

Substances

Anti-Ulcer Agents
Proton Pump Inhibitors